In English | En español

National Cancer Institute

at the National Institutes of Health

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI

Clinical Trials Search Results

Page Options

Email This Document

Clinical Trial Questions?
Get Help:
1-800-4-CANCER
LiveHelp online chat

Popular Resources

Help Using the NCI Clinical Trials Search Form
How to Find a Cancer Treatment Trial
Learn About Clinical Trials
About NCI's List of Cancer Clinical Trials
NCI Dictionary of Cancer Terms
NCI Drug Dictionary
Featured Clinical Trials Supported by NCI

View Content for:

Patients
Health Professionals

Display:

Title
Description with: Locations Eligibility
Full Trial Description
Custom

Results 1-21 of 21 for your search:

Drug:  zorubicin hydrochloride
Find trials that include:  Any drugs shown
Trial Status:  Closed

Hide Search Criteria

Show Search Criteria

Help with Results

Select All on Page Sort by: Show Results per Page

Phase III Combination Chemotherapy with ARA-C/RBD/VCR/PRED for Adults with Chronic Myelogenous Leukemia

Phase: Phase III
Type: Treatment
Status: Closed
Age: under 50
Sponsor:
Protocol IDs: MDA-DT-7978, NCI-V84-0021

Late Intensification with CROP (CTX/RBD/VCR/PRED) with or without Active Specific Immunotherapy for AML

Phase: Phase II
Type: Treatment
Status: Closed
Age: under 50
Sponsor:
Protocol IDs: MDA-DT-7745

Phase II Chemotherapy with Rubidazone for Children with Refractory Acute Lymphoblastic or Acute Myelogenous Leukemia

Phase: Phase II
Type: Treatment
Status: Closed
Age: under 21
Sponsor: NCI
Protocol IDs: POG-7818, MDAR-313

Phase II Chemotherapy with Rubidazone for Solid Tumors in Children

Phase: Phase II
Type: Treatment
Status: Closed
Age: 21 and under
Sponsor: NCI
Protocol IDs: POG-7843

Phase II Combination Chemotherapy with Rubidazone and DTIC for Advanced Sarcomas and Mesotheliomas

Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-7625, MDAR-134

Phase II Combination Chemotherapy with ROAP - RBD/VCR/ARA-C/PRED for Acute Leukemia

Phase: Phase II
Type: Treatment
Status: Completed
Age: over 50
Sponsor: NCI
Protocol IDs: SWOG-7626

Phase II Chemotherapy with Rubidazone for Previously Treated Adults with Acute Leukemia or CML Blast Transformation

Phase: Phase II
Type: Treatment
Status: Completed
Age: over 18
Sponsor: NCI
Protocol IDs: SWOG-7633, MDAR-193

Phase II Chemotherapy with Rubidazone for Advanced Breast Cancer

Phase: Phase II
Type: Treatment
Status: Closed
Age: 65 and under
Sponsor: NCI
Protocol IDs: SWOG-7726

Phase II Chemotherapy with Rubidazone for Lymphoma in Relapsing Patients Previously Untreated with Anthracycline Derivatives

Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-7734

10.

Phase II ROAP (RBD/VCR/ARA-C/PRED) vs ADOAP (ADR/VCR/ARA-C/PRED) with Intensification and/or Immunotherapy for Acute Leukemia

Phase: Phase II
Type: Treatment
Status: Completed
Age: over 15
Sponsor: NCI
Protocol IDs: SWOG-7823/24/25/26

11.

Phase II Study of Rubidazone for Advanced Carcinomas of the Lung, Adenocarcinomas of the Pancreas and Colon, and Other Tumors

Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: WSU-C-22877

12.

Phase II Chemotherapy with RBD vs ADR for Metastatic Breast Cancer in Previously Treated Patients

Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor:
Protocol IDs: MAYO-773201

13.

Phase II Chemotherapy with ADR-DNA Complex vs ADR vs Rubidazone plus Immunotherapy with C. Parvum for Metastatic Breast Carcinoma

Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MDA-DT-7624

14.

Phase I Chemotherapy with Intermittent Single High-Dose Rubidazone for Solid Tumors and Hematologic Malignancies

Phase: Phase I
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MDA-DT-7428

15.

ROAP - Rubidazone/VCR/ARA-C/PRED plus MER-BCG Immunotherapy for Acute Nonlymphocytic Leukemia

Phase: No phase specified
Type: Treatment
Status: Closed
Age: over 50
Sponsor:
Protocol IDs: MDA-DT-7635A

16.

ADOAP Induction plus ARA-C/TG Maintenance in PEPA with WBC Transfusions for Adult Acute Myelogenous Leukemia

Phase: No phase specified
Type: Treatment
Status: Closed
Age: under 50
Sponsor:
Protocol IDs: MDA-DT-7771

17.

Chemotherapy with ROAP (RBD/VCR/ARA-C/PRED) plus Immunotherapy with MER for Acute Myelogenous Leukemia in Patients Over Age 50

Phase: No phase specified
Type: Supportive care, Treatment
Status: Closed
Age: over 50
Sponsor:
Protocol IDs: MDA-DT-7760

18.

Combination Chemotherapy with ROAP (RBD/ARA-C/VCR/PRED), POMP (6-MP/VCR/MTX/PRED) and OAP (ARA-C/VCR/PRED) plus TG with or without MER for AML

Phase: No phase specified
Type: Treatment
Status: Closed
Age: under 60
Sponsor:
Protocol IDs: MDA-DT-7926

19.

Induction by AZC/RBD and Maintenance by Repetitive Sequences of AZC/RBD, AZC/CTX, AZC/TG, AZC/VCR/DM for Acute Myelocytic Leukemia

Phase: No phase specified
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: CLB-7703

20.

CROPAM Induction and ARA-C/6-TG Consolidation plus Autologous Bone Marrow Rescue and Antibiotics for Adult ALL, AUL, and LL

Phase: No phase specified
Type: Supportive care, Treatment
Status: Closed
Age: over 15
Sponsor:
Protocol IDs: MDA-DT-7833

21.

Combination Chemotherapy with Ifosfamide and Rubidazone in Acute Undifferentiated or Lymphoblastic Leukemia

Phase: No phase specified
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MDA-DT-7709

Select All on Page

Help with Results

We Can Answer Your Questions
1-800-4-CANCER
LiveHelp Online Chat

NCI Home
Contact Us
Policies
Accessibility
Viewing Files
FOIA
Site Help
Site Map